• OPEN AN ACCOUNT
Indian Indices
Nifty
25,492.30 -17.40
(-0.07%)
Sensex
83,216.28 -94.73
( -0.11%)
Bank Nifty
57,876.80 322.55
( 0.56%)
Nifty IT
35,117.65 -219.95
( -0.62%)
Global Indices
Nasdaq
16.76 83.45
(0.18%)
Dow Jones
6,751.11 9.79
(0.15%)
Hang Seng
50,211.07 -672.61
(-1.32%)
Nikkei 225
9,688.02 -47.76
(-0.49%)
Forex
USD-INR
88.62 -0.02
(-0.03%)
EUR-INR
102.12 0.31
(0.30%)
GBP-INR
116.02 0.48
(0.42%)
JPY-INR
0.58 0.00
(0.14%)

EQUITY - MARKET SCREENER

Marksans Pharma Ltd
Industry :  Pharmaceuticals - Indian - Formulations
BSE Code
ISIN Demat
Book Value()
524404
INE750C01026
30.5295026
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
MARKSANS
40.52
8281.57
EPS(TTM)
Face Value()
Div & Yield %
4.51
1
0.44
 

Elantas Beck India Ltd - Board Meeting Intimation for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended On 30Th September 2025
Oct 15,2025
Elantas Beck India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2025 inter alia to consider and approve unaudited financial results for the quarter and nine months ended on 30th September 2025